CLDN5 — Claudin-5

Pathway Diagram

flowchart TD
    CLDN5["CLDN5"]
    Blood_Brain_Barrier_Integrity["Blood-Brain Barrier Integrity"]
    CLDN5 -->|"component_of"| Blood_Brain_Barrier_Integrity
    BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
    CLDN5 -->|"involved_in"| BLOOD_BRAIN_BARRIER
    TIGHT_JUNCTION["TIGHT JUNCTION"]
    CLDN5 -->|"involved_in"| TIGHT_JUNCTION
    Blood_Brain_Barrier["Blood-Brain Barrier"]
    CLDN5 -->|"component_of"| Blood_Brain_Barrier
    Tight_Junctions["Tight Junctions"]
    CLDN5 -->|"involved_in"| Tight_Junctions
    MICROGLIA["MICROGLIA"]
    CLDN5 -->|"expressed in"| MICROGLIA
    Blood_Brain_Barrier_Disruption["Blood-Brain Barrier Disruption"]
    CLDN5 -->|"involved_in"| Blood_Brain_Barrier_Disruption
    AUTOPHAGY["AUTOPHAGY"]
    CLDN5 -->|"regulated_by"| AUTOPHAGY
    Autophagy["Autophagy"]
    Autophagy -->|"regulates"| CLDN5
    DTG["DTG"]
    DTG -.->|"downregulates"| CLDN5
    BRAIN_ARTERIOVENOUS_MALFORMATIONS["BRAIN ARTERIOVENOUS MALFORMATIONS"]
    BRAIN_ARTERIOVENOUS_MALFORMATIONS -.->|"downregulates"| CLDN5
    Brain_Arteriovenous_Malformations["Brain Arteriovenous Malformations"]
    Brain_Arteriovenous_Malformations -.->|"downregulates"| CLDN5
    h_7a8d7379["h-7a8d7379"]
    h_7a8d7379 -->|"therapeutic_target"| CLDN5
    CAV1["CAV1"]
    CAV1 -->|"mediates"| CLDN5
    ER_STRESS["ER STRESS"]
    ER_STRESS -.->|"downregulates"| CLDN5
    style CLDN5 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style Blood_Brain_Barrier_Integrity fill:#880e4f,stroke:#f48fb1,color:#f48fb1
    style BLOOD_BRAIN_BARRIER fill:#263238,stroke:#90a4ae,color:#90a4ae
    style TIGHT_JUNCTION fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Blood_Brain_Barrier fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Tight_Junctions fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style MICROGLIA fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Blood_Brain_Barrier_Disruption fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style AUTOPHAGY fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Autophagy fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style DTG fill:#263238,stroke:#90a4ae,color:#90a4ae
    style BRAIN_ARTERIOVENOUS_MALFORMATIONS fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Brain_Arteriovenous_Malformations fill:#4a0000,stroke:#ef5350,color:#ef5350
    style h_7a8d7379 fill:#263238,stroke:#90a4ae,color:#90a4ae
    style CAV1 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style ER_STRESS fill:#263238,stroke:#90a4ae,color:#90a4ae

Knowledge graph relationships for CLDN5 (306 total edges in KG)

Overview

CLDN5 (Claudin-5) is a critical tight junction protein that maintains blood-brain barrier (BBB) integrity. It is essential for the paracellular barrier that prevents harmful substances from entering the brain while allowing necessary nutrients to pass.

Introduction

Claudin-5 is encoded by the CLDN5 gene located on chromosome 22q11.21. It is a member of the claudin family of proteins that are the primary structural components of tight junctions. Tight junctions form a seal between adjacent endothelial cells in the blood-brain barrier, creating a physical barrier that controls the passage of ions, molecules, and cells between the blood and the brain [1].

The discovery that claudin-5 deficiency leads to increased BBB permeability to small molecules (<800 Da) demonstrated the critical role of this protein in maintaining BBB selectivity [2].

Gene Structure

The CLDN5 gene consists of 4 exons and encodes a protein of 218 amino acids. The gene is expressed predominantly in endothelial cells of the brain and lung vasculature.

Protein Structure

Claudin-5 is a transmembrane protein with:

• Four transmembrane domains

• Two extracellular loops: The first extracellular loop determines charge selectivity

• Cytoplasmic N- and C-termini: The C-terminus interacts with PDZ domain proteins

Normal Physiological Function

Blood-Brain Barrier Integrity

• Forms tight junction strands between brain endothelial cells

• Controls paracellular diffusion of small molecules

• Maintains endothelial polarity

Selective Permeability

• Size-selective barrier (blocks molecules >800 Da in claudin-5 deficient mice)

• Charge-selective barrier (negatively charged molecules)

• Maintains CNS homeostasis

Role in Neurodegeneration

Alzheimer’s Disease

• CLDN5 expression is altered in AD brains

• BBB breakdown correlates with cognitive decline

• Amyloid-beta deposition can disrupt tight junctions

• Therapeutic targeting may improve drug delivery [3]

Parkinson’s Disease

• CLDN5 dysfunction contributes to disease progression

• May affect alpha-synuclein clearance from the brain

• Relevant for understanding levodopa resistance

Stroke and Vascular Dementia

• Critically involved in stroke pathophysiology

• Post-stroke BBB repair is important for recovery

• Target for stroke therapeutics

Multiple Sclerosis

• Tight junction disruption is a hallmark of MS lesions

• CLDN5 is downregulated in active MS lesions

• Potential therapeutic target

Therapeutic Implications

Drug Delivery

• Targeting CLDN5 can enhance drug delivery to the brain

• Transient opening of BBB for drug delivery

• Focused ultrasound can modulate CLDN5

Biomarkers

• CLDN5 levels in blood may serve as BBB integrity markers

• CSF/serum ratio of CLDN5 indicates BBB damage

Gene Therapy

• Potential for restoring BBB function

• Viral vector delivery to endothelial cells

Key Publications

1. Nitta et al., Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice (2003). Journal of Cell Biology.

2. Wolburg et al., Tight junctions of the blood-brain barrier (2009). Neuroscience.

3. Sweeney et al., Blood-brain barrier breakdown in Alzheimer’s disease (2019). Nature Reviews Neurology.

Background

The study of Cldn5 — Claudin 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• NCBI Gene: https://www.ncbi.nlm.nih.gov/gene/9079

• UniProt: https://www.uniprot.org/uniprot/O00511

• Ensembl: https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184113

• Blood-Brain Barrier Overview

• Neurovascular Unit Alzheimer’s Disease

• Parkinson’s Disease

• Stroke

• Genes Index

• Proteins Index